In human monocytes, LL‑37 at 5 µg/ml suppressed 106 of the 125 genes up-regulated by 10 ng/ml LPS.
In plain wordsIn human immune cells, LL‑37 switched down most genes that bacterial LPS had switched on.
- Peptide
- LL-37
- Outcome
- DecreaseLPS-induced gene up-regulation (microarray)
- Study
humann: not reported in source
Human monocytic cells- Comparator
- LPS alone
- Outcome group
- Inflammation markers · Immune and inflammation
- Studied dose
- 5 µg/mlAs given in this study (human).
Measurements
- Genes up-regulated by LPS
- 125 genes
- human monocytes, 10 ng/ml LPS
- Up-regulated genes suppressed by LL-37
- 106 genes
- 5 µg/ml LL-37
Source sentences
Microarray studies indicated that 10 ng/ml LPS led to the up-regulation of 125 genes in human monocytes, 106 of which were suppressed in the presence of 5 mug/ml of the human peptide LL-37.
2 context sentences(design, population, supporting numbers)
In this study, temporal transcriptional expression profiles were analyzed in human and bovine monocytic cells in response to the TLR-4 agonist, LPS, in the presence or absence of their respective host defense peptides.
The cathelicidin peptides, human LL-37 and bovine myeloid antimicrobial peptide-27 (BMAP-27), are homologs, yet they have diverged notably in terms of sequence similarity.